The P2X 7 receptor (P2X 7 R)4 is highly expressed on the macrophage cell surface and activation of infected cells by extracellular ATP has been shown to kill intracellular bacteria and parasites. Furthermore, single nucleotide polymorphisms (SNPs) that decrease receptor function reduce the ability of human macrophages to kill Mycobacterium tuberculosis and are associated with extrapulmonary tuberculosis. In this paper we show that macrophages from people with the 1513C (rs3751143) loss-of-function P2X 7 R SNP are less effective in killing intracellular Toxoplasma gondii after exposure to ATP compared with macrophages from people with the 1513A wild-type allele. Supporting a P2X 7 R-specific effect on T. gondii, macrophages from P2X 7 R knock-out mice (P2X 7 R −/− ) are unable to kill T. gondii as effectively as macrophages from wild-type mice. We show that P2X 7 R-mediated T. gondii killing occurs in parallel with host cell apoptosis and is independent of NO production.
Introduction
The purinergic P2X 7 receptor (P2X 7 R) functions as a pro-inflammatory receptor in cells of the monocyte/macrophage lineage. P2X 7 R cell surface membrane expression is up-regulated by interferon-γ and the receptor is activated by extracellular ATP released from a variety of cellular sources including platelets and damaged cells (1) . Activation of monocyte and macrophage P2X 7 R has been shown to kill intracellular Mycobacterium (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , Chlamydia (12) (13) (14) , and Leishmania species (15) . The P2X 7 R gene (P2RX7) is highly polymorphic and a number of non-synonymous single nucleotide polymorphisms (SNPs) have been described that alter receptor function. The majority of SNPs, including 946G>A (rs28360457, Arg-307 to Gln), 1096C>G (rs2230911, Thr-357 to Ser), 1405A>G (rs2230912, Arg-460 to Gln), 1513A>C (rs3751143, Glu-496 to Ala) and 1729T>A (rs1653624, Ile-568 to Asn) confer a loss-of-function phenotype. Significantly, the loss-of-function 1513A>C SNP reduces the in vitro ability of human macrophages to control Mycobacterium tuberculosis (10) . Furthermore, inheritance of the 1513A>C SNP has been associated with susceptibility to extrapulmonary tuberculosis in humans (11, 16) .
Similar to Mycobacterium, Chlamydia, and Leishmania spp., the apicomplexan parasite, Toxoplasma gondii, is able to infect and survive in cells of the monocyte/macrophage lineage. Toxoplasma gondii is an obligate intracellular protozoa that infects approximately one-third of humans worldwide (17) . Human infection occurs after ingestion of either tissue cysts in raw/undercooked meat or oocysts from infected cat faeces and can be acquired congenitally following primary maternal infection. Although severe disease can occur in the immunocompetent human host, infection is usually asymptomatic or a mild illness characterised by malaise, lymphadenopathy, fever and headache (17) . Considerable morbidity and mortality in immunosuppressed individuals, in particular toxoplasmic encephalitis, is caused by reactivation of chronic infection and severe fetal abnormalities can occur in association with primary maternal infection (17) .
Herein we describe three immunocompetent people with toxoplasmosis who prompted further investigation of P2X 7 R as a factor influencing host-response to T. gondii infection. We show, in studies using human macrophages and P2X 7 R knockout (P2X 7 R −/− ) mice, that P2X 7 R activation by extracellular ATP kills T. gondii parasites in infected cells. P2X 7 Rmediated T. gondii death occurs in parallel with host-cell apoptosis and is independent of NO production.
Materials and Methods

P2X 7 R function and genotyping in toxoplasmosis subjects
Subjects from the Nepean Hospital, Penrith, New South Wales, Australia provided informed consent for study of their peripheral blood mononuclear cells. The experimental protocol was approved by the Sydney West Area Health Service and the University of Sydney Human Ethics Committees and the UTS Human Research Ethics Committee, with approval code: UTS HREC 2004-077A. Peripheral blood was collected, mononuclear cells were separated and macrophages generated and cultured as described previously (9) . Ethidium influx after activation of cells with 1 or 3mM ATP was measured by flow cytometry (7) and P2RX7 genotyping was performed as described previously (9) . Peripheral blood samples provided the DNA obtained from participants in the National Collaborative Chicago-based Congenital Toxoplasmosis Study (NCCCTS) (18) . Genotyping of these samples was performed using Taqman™ technology (19) for P2RX7 single nucleotide polymorphisms at rs28360457, rs1718119, rs2230911, rs2230912, rs3751143, rs1653624 and rs1621388 (NCBI Entrez SNP, http://www.ncbi.nlm.nih.gov/sites/entrez). Ethical approval for the NCCCTS was obtained from the Institutional Review Boards of the University of Chicago and Michael Reese Hospital and Medical Center, and oversight was provided by an Internal Data Safety Monitoring Committee, the Data Safety Monitoring Board, and the NIH.
Murine macrophage culture
The immortalised mouse macrophage-like cell line RAW 264.7, was cultured as described previously (20) . All animal research was approved and conducted in accordance with the University of Technology, Sydney Animal Care and Ethics Committee, with approval code UTS ACEC 2008-30. Murine bone marrow was isolated from BALB/c (Animal Resource Centre, Murdoch, Western Australia), C57BL/6J (Animal Resource Centre, Murdoch, Western Australia) and mice on a C57BL/6J background with the P2RX7 gene deleted (P2X 7 R −/− mice, originally obtained from Pfizer, Ann Arbor, MI, USA, and subsequently bred at the Ernst Facility, University of Technology, Sydney) and bone marrow macrophages were cultured as described previously (21) .
Toxoplasma gondii viability assays
Three assays were used to assess viability of T. gondii in vitro, ensuring a robust assessment of effect of activation of cells by ATP (1 or 3mM) on survival and replication of tachyzoites.
YFP-YFP RH T. gondii (a gift from Dr Boris Striepen, the University of Georgia, Athens, GA, USA) replication in cultured monocyte-macrophages was monitored as described previously (22) at the University of Chicago Cellular Screening Centre using an F3 robot and Acumen eX3 microplate cytometer. Hourly measurements of fluorescent parasites were conducted for a total period of 24 hours, with three initial measurements taken prior to the addition of ATP to half of the cell samples for each person immediately prior to the fourth measurement.
In addition, a flow cytometry-based viability assay for intracellular T. gondii tachyzoites was established that allowed rapid assessment of viability of thousands of intracellular T. gondii tachyzoites. Cells were infected with T. gondii tachyzoites, incubated overnight and extracellular tachyzoites removed. Intracellular tachyzoites were released by mechanically lysing host cells and parasite viability assessed by flow cytometry. Prior to experiments, anti-p30 T. gondii monoclonal antibody was first conjugated to Alexa Fluor 647 using the Alexa Fluor 647 protein labelling kit according to the manufacturer's instructions. Antibody was combined with Alexa Fluor 647 dye, incubated at room temperature and separated from unbound dye by size exclusion chromatography. Tachyzoite viability was assessed using flow cytometry by staining the cell suspension with anti-p30 T. gondii-Alexa Fluor 647 conjugated monoclonal antibody diluted 1:100 and Sytox Green diluted 1:10000. Previously prepared 97 mL tachyzoite suspensions were combined with 1mL anti-p30 T. gondii-Alexa Fluor 647 conjugated monoclonal antibody and 2mL Sytox Green working solution (diluted 1:200) and incubated at room temperature for 30 minutes protected from light, mixing the suspension gently after 15 minutes. Following incubation, 500 mL PBS plus 1% BSA and 0.05% NaN 3 was added and the suspension transferred to a FACS tube for analysis on a BD FACSCalibur flow cytometer. Tachyzoites were identified by log increases in anti-p30 T. gondii-Alexa Fluor 647 conjugated monoclonal antibody fluorescence, measured on the FL-4 detector. Tachyzoite viability was analysed based on Sytox Green uptake, measured on the FL-1 detector. Following the acquisition of 5000 gated tachyzoite events, listmode data files were removed from the FACSCalibur Macintosh computer using a portable USB storage device and transferred to a PC for analysis with the free flow cytometry analysis software, WinMDI, version 2.9. Tachyzoites were gated for viability analysis, with the resulting bimodal populations corresponding to viable (Sytox Green non-fluorescent) and non-viable (Sytox Green fluorescent) tachyzoites. Percent viable T. gondii tachyzoites were plotted using GraphPad Prism, version 5.00.
For the RAW 264.7 line, cells were seeded into Labtek II 8 well chamber slides (Nunc) at a density of 5×10 4 /well and left to grow overnight. The following day, 1×10 5 freshly lysed T. gondii tachyzoites were added to appropriate wells and left to invade for 2 hours at 37°C in 5% CO 2 . Uninvaded parasites were removed and then the infected cells were treated with ATP, pH 7.4, for 1 hour at 37°C in 5% CO 2 . The media was carefully removed and the chamber discarded. Determination of viability was undertaken using acridine orange and ethidium bromide as described previously (23) (24) (25) . Cells and parasites were viewed on an Olympus BX51 fluorescent microscope with excitation filter 470/20nm. A minimum of 300 cells or intracellular parasites were counted per sample and the assay was repeated in duplicate on at least three separate occasions. Images were taken using an Olympus DP70 digital camera at 1000× magnification.
In vivo parasite burden and NO assay
Eight-week-old male mice were infected by intraperitoneal injection of 500 tachyzoites of T. gondii RH or ME49 strain. Splenic parasite burdens were determined for individual mice using a modification of the method described previously (26) . Briefly, spleens were removed and placed into RPMI containing 5% fetal calf serum. Spleens were weighed and single cell suspensions were made by passing spleens through a 70µm sieve. Cells were pelleted at 1500 g then resuspended in 4 ml RPMI containing 5% fetal calf serum. One hundred microlitres was added to the first well of a 96 well plate and splenocytes were serially diluted 1/2 across the plate. Plates were incubated at 37°C in 5% CO 2 for 8 days before wells were examined for the presence of parasites. Parasite burden was determined as the last well in which a single parasite was visible and the number of parasites per gram was calculated thus: (mean of reciprocal titers from each duplicate/weight of homogenized spleen) × 400, where 400 is the reciprocal fraction of the homogenized spleen inoculated into the first sample well. Serum was collected from the same mice and assayed for NO using the Griess assay, as described previously (27) .
Annexin-V-FITC and propidium iodide apoptosis
RAW 264.7 cells were seeded into 6-well plates containing drop-in Teflon cups (Savillex, USA) at a density of 1×10 6 cells per well. Toxoplasma gondii tachyzoites (1×10 6 ) were infected into each well overnight, prior to the addition of ATP to activate P2X 7 receptors. Apoptosis was assessed after addition of ATP using the Annexin-V-FITC apoptosis detection kit (Calbiochem/Merck, Germany), according to the manufacturer's instructions. Annexin-V-FITC and propidium iodide fluorescence were assessed using a FACSCalibur flow cytometer (Becton Dickinson, USA).
Results
Description of three immunocompetent subjects with toxoplasmosis and reduced or absent P2X 7 R function
Subject 1 (S1), a 14-year-old male, presented to the Nepean Hospital, Penrith, Australia, with a 2-year history of fatigue, lethargy and generalized painless lymphadenopathy. There was no resolution of symptoms after multiple courses of antibiotic therapy. Toxoplasma gondii serology was positive for IgM and negative for IgG. A biopsy of an enlarged left axillary lymph node showed lymphadenitis consistent with toxoplasmosis. Symptoms resolved after treatment with sulfadiazine and pyrimethamine and convalescent serology was positive for Toxoplasma IgG and negative for IgM. Subject 2 (S2), a 20-year-old female, presented with an enlarged submandibular lymph node 5 weeks following a dental extraction. Excision lymph node biopsy and histology was consistent with T. gondii lymphadenitis and T. gondii serology was positive for IgM and IgG. Repeat serology 2 years later was positive for IgG and negative for IgM. Subject 3 (S3), a 24-year-old pregnant female, had a routine fetal ultrasound scan at 18 weeks gestation, which showed borderline fetal cerebral ventriculomegaly. A repeat scan at 22 weeks gestation showed prominent cerebral ventriculomegaly. A diagnostic amniocentesis was performed and PCR for the T. gondii-gene was positive.
In all three subjects there was no evidence of any major underlying immunodeficiency: HIV serology was negative; absolute lymphocyte numbers and lymphocyte subsets were normal; absolute neutrophil counts were normal; and serum immunoglobulin levels were normal ( Fig. 1A) . However, all three people displayed impaired macrophage P2X 7 R function measured by ATP-induced ethidium bromide uptake that was either reduced to approximately half (S1) or completely absent (S2 and S3) compared to control people (Fig.  1B) . Moreover, P2RX7 genotyping showed S1 was heterozygous for 1513A>C, S2 was heterozygous for both 946G>A and 1096C>G and S3 was heterozygous for both 946G>A and 1513A>C, loss-of-function SNPs (Fig. 1C) .
ATP-dependent macrophage killing of Toxoplasma gondii is reduced in people with decreased P2X 7 R function
Genotyping of the NCCCTS cohort ( Fig. 2A) identified people with the most common loss of function polymorphism in P2RX7, the 1513A>C polymorphism (28) , as well as those with wild-type P2RX7 or polymorphisms in linkage disequilibrium (1068G>A and 1772G>A) that do not reduce the function of the receptor (28) . A reduction in parasite burden was observed following ATP treatment of monocyte-derived macrophages from people with wild-type P2RX7 or with no loss of function polymorphisms (Fig. 2B) . Conversely, ATP treatment of monocyte-derived macrophages cultured from people who are homozygous for the 1513A>C loss-of-function polymorphism had minimal effect on the number of intracellular T. gondii tachyzoites (Fig. 2B ).
ATP-dependent macrophage killing of Toxoplasma gondii is reduced in P2X 7 R −/− mice
The number of samples and the quantity of cells from people in the NCCCTS cohort with polymorphisms in their P2X 7 R was relatively limited. Therefore, P2X 7 R −/− mice on a C57BL/6J background were also used to more definitively assess the ability of the P2X 7 R to mediate killing of T. gondii tachyzoites by macrophages. C57BL/6 mice possess a proline to leucine polymorphism at amino acid 451 in the C-terminal tail of the P2X 7 R (29). This polymorphism has variable effects on P2X 7 R function (29) (30) (31) (32) (33) (34) , so we included comparative analyses of BALB/c cells in our investigations since this strain of mouse is known to possess fully functional P2X 7 R (29-34) and is also known to be more resistant to T. gondii than C57BL/6J mice (35) . P2X 7 R function of macrophages from BALB/c, C57BL/6J and P2X 7 R −/− mice was determined, confirming 100%, 50% and zero P2X 7 R-dependent pore opening, respectively (Supplemental Fig. 1 ). ATP treatment of macrophages from BALB/c and C57BL/6J mice resulted in a marked reduction in viability of T. gondii RH strain. In contrast, ATP treatment of P2X 7 R −/− murine macrophages produced no significant loss of T. gondii viability (Fig. 3) . Very similar results were seen with the relatively avirulent, type 2 ME49 strain of T. gondii; exposure of BALB/c macrophages to ATP reduced parasite viability from 81 ± 4% to 49 ± 12%, in C57BL/6J macrophages, from 83 ± 2% to 49 ± 12% but, in P2X 7 R KO mice, parasite viability remained unchanged at 82 ± 4% (versus 83 ± 3% in non-activated cells; results are mean ± SE, n=3).
There were significant differences in the number of parasites recovered from the spleens of ME49-infected mice: on day 12 pi, for BALB/c mice, 1693 ± 238 parasites per gram spleen were recovered versus 2353 ± 500 for C57BL/6J mice and 2892 ± 298 for P2X 7 R −/− mice (results are means ± SE, n=6, and there were significantly more parasites recovered from the P2X 7 R −/− mice, p<0.05, Mann-Whitney non-parametric test).
P2X 7 R-mediated killing of Toxoplasma gondii is independent of NO production but is associated with host cell apoptosis
To test if killing of T. gondii after P2X 7 R activation is dependent on NO production, we compared serum NO levels from P2X 7 R −/− mice to BALB/c and C57BL/6J mice after infection by intraperitoneal injection of T. gondii RH strain tachyzoites. There was a trend towards higher serum NO levels in the P2X 7 R-deficient infected mice although none of the differences achieved statistical significance; thus, control of T. gondii RH strain via the P2X 7 R is independent of NO production ( Fig. 4) .
RAW 264.7 cells express functional P2X 7 R (Supplemental Fig. 2 ). Exposure to ATP induced rapid apoptosis of T. gondii-infected RAW 264.7 cells; more than 70% of cells were positive for Annexin-V by 1 hour (Fig. 5A) . At 5 hours post-exposure to ATP, a significant percentage (>30%) of apoptotic cells had progressed towards lysis (Fig. 5A ). Similar levels of ATP-induced apoptosis and necrosis were seen in uninfected RAW 264.7 cells (data not shown).
In situ staining of RAW264.7 cells with acridine orange and ethidium bromide confirmed the Annexin V/propidium iodide flow cytometry results. Acridine orange is able to penetrate all cells and stains nucleic acids green, whereas ethidium bromide, which binds to nucleic acids and fluoresces orange, is only able to enter cells once the integrity of the cell membrane is compromised. Thus, live cells have normal nuclear staining with green chromatin apparent in organised nuclear structures, whereas non-viable cells exhibit orange staining of nuclear material and/or condensed or fragmented chromatin (23) (24) (25) . Cells were viewed and counted on a fluorescence microscope and the viability of RAW 264.7 cells was assessed according to these criteria (Fig. 5C ). Thus, 54% of RAW264.7 cells were nonviable after 1 hour and 86% non-viable within 2 hours of exposure to ATP, compared with 4% and 7%, respectively, for untreated cells. Furthermore, at 2 hours post-exposure to ATP, intensely stained, condensed, fragmented areas of chromatin were evident within the nuclei of host cells (Fig. 5C, panel 3) . At later time points, microscopic examination revealed extensive cell lysis.
In situ staining with acridine orange and ethidium bromide also showed that loss of viability of intracellular tachyzoites of T. gondii occurred in parallel to host cell apoptosis. Thus, 5 minutes post-exposure to ATP, almost all tachyzoites were stained green with acridine orange (Fig. 5B, panel 1 ) and, after 1 hour, the parasites were still predominantly (73%) acridine orange-positive and ethidium bromide-negative ( Fig. 5B, panel 2; Fig. 5C ). However, by 2 hours post-exposure to ATP, 43% of the parasites were stained orange with ethidium bromide (Fig. 5B, panel 3; Fig. 5C ). Meanwhile, tachyzoites exposed to ATP in cell-free media remained 100% viable, even after 2 hours (data not shown). This demonstrates that a direct toxic effect of exogenous ATP on T. gondii is unlikely; rather, ATP acts via effects on the host cell. By 24 hours post-exposure to 1mM ATP, flow cytometric assessment of parasite viability showed that only 25 ± 5% (mean ± SE, n=4) of T. gondii tachyzoites were viable, a result comparable with the effect of 3mM sodium nitroprusside (28 ± 5% viable, mean ± SE, n=4), a known toxin for T. gondii tachyzoites (36) . This viability was statistically significantly different (p<0.001, General Linear Model 2-facot ANOVA with Tukey's post-hoc test) from controls at the same time-point where 70 ± 8% (mean ± SE, n=4) of tachyzoites in control cultures were viable, a level not statistically different from the number of viable parasites after 2, 8 or 16 hours of normal in vitro culture (data not shown). The effects on intracellular T. gondii of exposure to ATP could be totally reversed by pre-treatment of RAW264.7 cells with oxidized ATP (data not shown), a potent antagonist of the murine P2X 7 R (37), further aiding in confirmation of the specificity of the effect. Discussion P2X 7 R genotyping and relative P2X 7 R activity of three acute toxoplasmosis patients from Nepean Hospital, Australia (Fig. 1) is consistent with previous studies showing 50% reduction in monocyte P2X 7 R function in 1513A>C heterozygotes and complete loss-offunction for compound heterozygotes (8, 9, 11) . To follow up the surprising association between P2X 7 R function and acute symptoms in these patients, and to study the effect of polymorphisms at P2RX7 on function in more detail, we accessed cryopreserved cells from NCCCTS individuals of known genotypes/haplotypes (20) . We demonstrated that ATPdependent killing of tachyzoites of T. gondii in vitro was virtually non-existent in people with the 1513A>C polymorphism but readily observable in macrophages from people with wild-type receptors or in cells from people with polymorphisms that do not cause loss of receptor function (Fig. 2) .
The number of cells available from NCCCTS subjects was limited and did not allow us to perform additional, confirmatory studies with antagonists of the P2X 7 R. Therefore, we compared parasite killing using macrophages from P2X 7 R −/− mice to BALB/c mice and C57BL/6J mice to confirm that reduced parasite killing is P2X 7 R specific; cells from the knockout mice were totally unable to affect the viability of T. gondii upon activation with ATP ( Fig. 3) . These data confirm that ATP-dependent macrophage killing of T. gondii is via P2X 7 R and does not involve other P2X or P2Y receptors, which are also activated by extracellular ATP (37) . Parasite burden in vivo in BALB/c, C57BL/6J and P2X 7 R −/− mice appears to at least partially confirm that the P2X 7 R plays a role in controlling T. gondii. Thus, there were differences in the number of parasites recovered from the spleens of ME49-infected mice, in proportions consistent with their relative P2X 7 R function.
It perhaps needs to be noted that ATP-induced killing of T. gondii was comparable in BALB/c and C57/BL/6J mice even though the C57/BL6 strain is known to possess a proline to leucine polymorphism at amino acid 451 that reduces ATP-dependent pore formation by 50% ( Supplemental Fig. 1 ). This could be because of the higher concentration of ATP used in the parasite-killing assay versus the pore-opening assay (3mM versus 1mM). However, it is also important to recognise that this particular polymorphism has quite variable effects on P2X 7 R function depending on the cell type and activity being examined. Thus, for example, it reduces ATP-dependent pore formation (29) , impairs cell death in thymocytes (30), inhibits ATP-induced IL-2 production by splenocytes (31) and affects intercellular calcium waves in astrocytes (32) . In contrast, this polymorphism has no affect on phospholipase D activation (30) , no affect on expression of the P2X 7 R or sensitivity to ATP-induced cell death in splenic CD4 + CD25 + T cells (33) , and no affect on P2X 7 R-mediated calcium influx in bone marrow derived macrophages or splenocytes (34) .
Activation of the P2X 7 R initiates a cascade of intracellular events including activation of NFκB (38) , phospholipase D (39) and metalloproteases (40) , release of reactive oxygen and nitrogen intermediates (41) , and stimulation of caspases, leading to apoptosis (42) . Loss of function polymorphisms in the P2X 7 R are also recognised (43, 44) to have a negative effect on the activation of the "inflammasome", a complex of cytosolic proteins that regulates caspase-1 activation and, therefore, the processing of IL-1β and IL-18 from inactive to active forms. It is known that killing of mycobacteria and Leishmania amazonensis via the P2X 7 R is independent of NO (3, 6, 15) ; rather it is associated with apoptosis of host cells (2, 3, 7, 8, 10, 11, 15) , as is P2X 7 R-mediated killing of Chlamydia (12) . We confirmed that P2X 7 R-mediated killing of T. gondii is also not associated with NO levels (Fig. 4) . To test if T. gondii killing was associated with apoptosis, we studied in vitro parasite death in RAW 264.7 cells after induction of apoptosis with ATP. Both flow cytometry and in situ staining with acridine orange and ethidium bromide enabled us to document that loss of viability of intracellular tachyzoites of T. gondii occurred in parallel to host cell apoptosis (Fig. 5 ).
The vulnerability of T. gondii to ATP-induced, P2X 7 R-mediated killing shares much in common with similar phenomena observed with Mycobacteria (2-11), Chlamydia (12) (13) (14) and Leishmania (15) species, not least the association with apoptosis and independence from NO generation. However, there are likely to be differences too; P2X 7 R-dependent killing of Mycobacteria and Chlamydia species is actually dependent on phospholipase D, which is associated with both apoptosis and phagosome-lysosome fusion (4) (5) (6) 13) . This scenario seems less likely for T. gondii as the parasite inhibits phagosome-lysosome fusion after active penetration of the host cell and modification of phagosomal membrane proteins (45) (46) (47) . A role for caspase-1 and subsequent release of mature IL-1β, which can cause apoptosis in surrounding cells (37) , can also be ruled out because RAW264.7 cells lack the key adaptor protein, ASC (apoptosis-associated speck-like protein containing a C-terminal caspase-activating recruiting domain), to form the inflammasome (48) . Whilst the limitations of the correlative link between host cell apoptosis and parasite killing must be acknowledged, we believe that, on balance, this effect is likely to be P2X 7 R-specific and does not imply that just any pro-apoptotic agent will cause killing of this parasite. This is because of the extremely well demonstrated ability of T. gondii to inhibit apoptosis induced by a remarkable spectrum of extrinsic and intrinsic pro-apoptotic stimuli in a variety of host cell types (49) (50) (51) (52) (53) (54) (55) . It is also worth noting that apoptosis induced by CD-95 ligation or by H 2 0 2 or necrosis induced by complement does not directly influence the survival of mycobacteria within macrophages (3). Thus, whilst we have shown that host cell apoptosis is a potential effector mechanism of parasite killing via P2X 7 R activation, the precise mechanism underpinning this remains to be definitively determined.
Our observations suggest that inheritance of SNPs that reduce P2X 7 R function might cause a defective response to T. gondii infection, higher risk of reactivation in immunocompromised people and more severe congenital toxoplasmosis. Genotyping P2RX7 in these patient groups and identifying those at risk would allow for more intensive monitoring for reactivation of infection and, if required, suppressive treatment using anti-Toxoplasma therapy.
Figure 1. Studied acute toxoplasmosis subjects have normal immune function but have low P2X 7 R function due to P2X 7 R loss-of-function SNPs
(A) Hb = haemoglobin (Hb; g/L), WCC = white cell count (WCC; ×10 9 cells/L), absolute lymphocyte counts (Abs lymph; × 10 9 cells/L), CD4+ lymphocyte counts (CD4; ×10 6 cells/ L), CD8+ lymphocyte counts (CD8; ×10 6 cells/L), serum immunoglobulins (Serum Ig), HIV serology for human immunodeficiency virus (HIV) was negative for all subjects. (ND = not determined). (B) Monocyte-derived macrophages from S1-3 and from subjects wild-type for known loss-of-function P2X 7 R SNPs were treated with 1mM ATP, followed by quantification of ethidium bromide flux through P2X 7 R generated pores by time-resolved flow cytometry. P2X 7 R function of cultured monocyte derived macrophages from S1-3 was decreased in comparison to three normal control subjects. (C) Sequencing of the P2RX7 gene shows the presence of one or more non-synonymous SNPs in all three toxoplasmosis subjects. a loss-of-function SNP.
Figure 2. Activation of human monocyte-derived macrophages with ATP fails to affect the viability of Toxoplasma gondii in the absence of functional P2X 7 receptors
(A) P2RX7 haplotypes identified in NCCCTS samples after genotyping for seven single nucleotide polymorphisms; haplotype 1 is wild type at all seven SNP locations, haplotype 2 is homozygous for the non-loss-of-function SNPs at nucleotides 1068 and 1772, and haplotype 3 is homozygous for the loss of function single nucleotide polymorphism at nucleotide 1513. (B) Intracellular T. gondii (RH) tachyzoite numbers were assessed in ATPtreated (3mM) monocyte-derived macrophages from NCCCTS samples. The reduction in fluorescence of YFP-labelled T. gondii parasites measured by flow cytometry in ATPtreated cells was calculated at 24 hours as a percentage of the untreated control for each subject. Results are the mean ± SE, n=3-6. There is a significantly lower percentage of parasites following ATP treatment in cells expressing functional P2X 7 R than in cells with the P2X 7 R 1513A>C loss-of-function SNP (p = 0.0015 using a General Linear Model, 1factor ANOVA with Tukey's post-hoc test). T. gondii RH strain tachyzoites (3×10 6 ) were added to 1×10 5 macrophages and parasite viability was assessed by flow cytometry 24 hours after addition of 3mM ATP. Parasite viability was significantly reduced in ATP-treated macrophages from BALB/c (p<0.0001) and C57BL/6J (p<0.0001) mice compared with untreated controls. Parasite viability was not significantly reduced after the addition of ATP to macrophages from P2X 7 R −/− mice (p>0.05). Results are the mean ± SE, n=4. Statistical analysis was performed using a General Linear Model 1-factor AVOVA with Tukey's post-hoc test. Mice were infected by intra-peritoneal injection with 500 RH T. gondii tachyzoites and euthanized 8 days post infection. Serum was collected and assayed for NO using the Griess Assay. Results are the mean ± SE; BALB/c control/infected, n=5/8; C57BL/6J control/ infected, n=5/9; P2X 7 R −/− control/infected, n=5/5. There were no statistically significant differences in serum NO levels between strains for mice infected with T. gondii (using a General Linear Model 1-factor ANOVA with Tukey's post-hoc test).
